{"id":"acetaminophen-or-equivalent","safety":{"commonSideEffects":[{"rate":null,"effect":"Hepatotoxicity (at high doses or chronic use)"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1647","moleculeType":"Small molecule","molecularWeight":"327.29"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Acetaminophen is believed to work primarily through inhibition of cyclooxygenase (COX) enzymes in the brain and spinal cord, reducing the production of prostaglandins that mediate pain and fever signaling. Unlike NSAIDs, it has minimal peripheral anti-inflammatory effects. The exact mechanism remains incompletely understood, but central nervous system effects on pain perception and thermoregulation are primary.","oneSentence":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:58:55.008Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mild to moderate pain"},{"name":"Fever reduction"}]},"trialDetails":[{"nctId":"NCT06841354","phase":"PHASE3","title":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-16","conditions":"Triple Negative Breast Neoplasms","enrollment":1000},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT06305754","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-11","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":520},{"nctId":"NCT06824467","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-09","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":770},{"nctId":"NCT06312137","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-03","conditions":"Non Small Cell Lung Cancer","enrollment":780},{"nctId":"NCT07318558","phase":"PHASE3","title":"A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-02-16","conditions":"Ovarian Neoplasms, Ovarian Cancer","enrollment":900},{"nctId":"NCT06170788","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-15","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":614},{"nctId":"NCT06393374","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-24","conditions":"Triple-Negative Breast Cancer","enrollment":1530},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT07216703","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-19","conditions":"Cervical Cancer","enrollment":1023},{"nctId":"NCT03258593","phase":"PHASE1","title":"Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2018-06-07","conditions":"Urinary Bladder Neoplasms","enrollment":15},{"nctId":"NCT06445972","phase":"PHASE1, PHASE2","title":"Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-08-07","conditions":"Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms","enrollment":210},{"nctId":"NCT07286149","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-23","conditions":"Lung Neoplasm Malignant","enrollment":190},{"nctId":"NCT05807048","phase":"PHASE2","title":"Daratumumab in STK11 Mutated NSCLC","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-06-01","conditions":"Non-small Cell Lung Cancer With STK11/LKB1 Mutation","enrollment":8},{"nctId":"NCT06788912","phase":"PHASE2","title":"Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-20","conditions":"Lung Neoplasm Malignant","enrollment":60},{"nctId":"NCT05039619","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-12","conditions":"Lupus Nephritis","enrollment":40},{"nctId":"NCT06356311","phase":"PHASE3","title":"A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-03","conditions":"Gastroesophageal Cancer","enrollment":450},{"nctId":"NCT06356571","phase":"PHASE2","title":"A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-03-17","conditions":"Plasma Cell Myeloma Refractory","enrollment":64},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT07419295","phase":"PHASE3","title":"A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)","status":"NOT_YET_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-17","conditions":"Bladder Cancer","enrollment":590},{"nctId":"NCT06074588","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-12","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":556},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT06132958","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-06","conditions":"Endometrial Cancer","enrollment":710},{"nctId":"NCT04629248","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-06-25","conditions":"Primary Membranous Nephropathy","enrollment":142},{"nctId":"NCT06460961","phase":"PHASE1","title":"A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-14","conditions":"Neoplasm Metastasis","enrollment":168},{"nctId":"NCT03297073","phase":"NA","title":"Paracetamol Metabolism Research in Postoperative Hepatic Surgery","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-11-20","conditions":"Paracetamol Causing Adverse Effects in Therapeutic Use, Hepatic Disease","enrollment":90},{"nctId":"NCT05627557","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2023-03-29","conditions":"Childhood Idiopathic Nephrotic Syndrome","enrollment":85},{"nctId":"NCT04270409","phase":"PHASE3","title":"Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2020-06-16","conditions":"Plasma Cell Myeloma","enrollment":337},{"nctId":"NCT06645678","phase":"PHASE1, PHASE2","title":"Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"YOUNGIL KOH","startDate":"2024-11-26","conditions":"Relapsed Refractory Multiple Myeloma (RRMM)","enrollment":75},{"nctId":"NCT05405166","phase":"PHASE3","title":"SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2022-06-23","conditions":"Plasma Cell Myeloma Recurrent","enrollment":531},{"nctId":"NCT03823534","phase":"PHASE3","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2019-02-20","conditions":"Bone Metastases, Lymphoma, Multiple Myeloma","enrollment":60},{"nctId":"NCT04294459","phase":"PHASE1, PHASE2","title":"Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation","status":"TERMINATED","sponsor":"Sanofi","startDate":"2020-06-18","conditions":"Immune System Disorder","enrollment":23},{"nctId":"NCT05834569","phase":"PHASE4","title":"Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients","status":"TERMINATED","sponsor":"Korea University Guro Hospital","startDate":"2023-06-15","conditions":"Delirium, Aged, Lung Neoplasms","enrollment":25},{"nctId":"NCT00712712","phase":"PHASE2","title":"Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer","status":"COMPLETED","sponsor":"Institut Bergonié","startDate":"2007-12-24","conditions":"Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":78},{"nctId":"NCT07109284","phase":"PHASE2","title":"SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-09","conditions":"ER+HER2- Breast Cancer","enrollment":55},{"nctId":"NCT06861920","phase":"PHASE4","title":"NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2025-04-07","conditions":"Dysmenorrhea, Chronic Pelvic Pain, Pelvic Pain","enrollment":600},{"nctId":"NCT07035561","phase":"PHASE2","title":"Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis","status":"COMPLETED","sponsor":"Shereen Medhat Mohammed Elsayed Nassar","startDate":"2023-06-01","conditions":"Hypersenstivity Pneumonitis, ILD","enrollment":30},{"nctId":"NCT04165096","phase":"PHASE2","title":"KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-01-21","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":128},{"nctId":"NCT01998971","phase":"PHASE1","title":"A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-02-18","conditions":"Multiple Myeloma","enrollment":240},{"nctId":"NCT03020875","phase":"PHASE4","title":"IV vs Oral Acetaminophen in Spine Fusion Perioperative Care","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-01","conditions":"Multimodal Analgesic Approach","enrollment":166},{"nctId":"NCT03836014","phase":"PHASE3","title":"Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-07-25","conditions":"Multiple Myeloma in Relapse","enrollment":436},{"nctId":"NCT04879823","phase":"PHASE3","title":"Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity","status":"TERMINATED","sponsor":"David Chi, MD","startDate":"2021-08-05","conditions":"Adenotonsillectomy, Analgesia, Surgery","enrollment":222},{"nctId":"NCT03192566","phase":"PHASE3","title":"Acetaminophen Dosing in Obese Adolescents","status":"SUSPENDED","sponsor":"Children's National Research Institute","startDate":"2016-08","conditions":"Obesity, Childhood","enrollment":6},{"nctId":"NCT04123717","phase":"EARLY_PHASE1","title":"Pilot Study Comparison Of Intravenous Ibuprofen And Intravenous Paracetamol In Management Of Pediatric Fever","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2019-10-11","conditions":"Fever","enrollment":147},{"nctId":"NCT05574504","phase":"PHASE2","title":"Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy","status":"WITHDRAWN","sponsor":"AdventHealth","startDate":"2023-05-08","conditions":"Metastatic Cancer, Urothelial Carcinoma","enrollment":""},{"nctId":"NCT02867800","phase":"PHASE1","title":"Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease","status":"COMPLETED","sponsor":"Monica Bhatia","startDate":"2016-07","conditions":"Sickle Cell Disease, Graft Versus Host Disease","enrollment":24},{"nctId":"NCT04882202","phase":"NA","title":"Acetaminophen and AKI After Aortic Surgery","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2021-10-01","conditions":"Aortic Surgery","enrollment":136},{"nctId":"NCT04840615","phase":"PHASE1","title":"Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-06-11","conditions":"Mesothelioma","enrollment":2},{"nctId":"NCT01070212","phase":"NA","title":"Effects of Gum Chewing on Appetite and Digestion","status":"COMPLETED","sponsor":"Purdue University","startDate":"2010-02","conditions":"The Null Hypothesis is That Food Rheology Will Have no Effect on These Indices, The Alternate Hypothesis is That Increased Mechanical Stimulation Will Result in Stronger Satiation/Satiety and Reduced Energy Intake, It is Hypothesized That the Effects of Mastication Will be Less Evident in Obese Compared to Lean Individuals","enrollment":60},{"nctId":"NCT02661035","phase":"PHASE2","title":"Allo HSCT Using RIC for Hematological Diseases","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-03-09","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":156},{"nctId":"NCT04648540","phase":"EARLY_PHASE1","title":"Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT01086540","phase":"PHASE2","title":"Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-06-24","conditions":"Systemic Sclerosis-Associated PAH","enrollment":57},{"nctId":"NCT05691088","phase":"NA","title":"Clinical Efficacy of Acetaminophen in Mechanical Ventilation in Children With New Coronary Pneumonia","status":"UNKNOWN","sponsor":"The Second Clinical Medical College of Jinan University","startDate":"2022-12-15","conditions":"Acetaminophen,Mechanical Ventilation,Critically Ill Children","enrollment":128},{"nctId":"NCT03883893","phase":"PHASE2","title":"IV Acetaminophen and Post-Tonsillectomy Pain","status":"WITHDRAWN","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-12","conditions":"Tonsillectomy, Adenoidectomy","enrollment":""},{"nctId":"NCT05298683","phase":"PHASE2","title":"A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor","status":"UNKNOWN","sponsor":"Hellenic Society of Hematology","startDate":"2022-05","conditions":"Multiple Myeloma, Renal Impairment, Neoplasms, Plasma Cell","enrollment":108},{"nctId":"NCT04899401","phase":"NA","title":"Trial To Assess Efficacy and Safety of PediaFlu® in Children With Acute Tonsillopharyngitis / Rhinopharyngitis","status":"COMPLETED","sponsor":"Pediatrica S.r.l","startDate":"2021-06-03","conditions":"Tonsillopharyngitis, Rhinopharyngitis","enrollment":130},{"nctId":"NCT04673214","phase":"PHASE3","title":"Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment","status":"COMPLETED","sponsor":"Gilberto Cruz Arteaga","startDate":"2020-12-16","conditions":"Covid19","enrollment":114},{"nctId":"NCT02260934","phase":"PHASE2","title":"Rituximab and Belimumab for Lupus Nephritis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-07-09","conditions":"Lupus Nephritis","enrollment":43},{"nctId":"NCT03570320","phase":"NA","title":"Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?","status":"COMPLETED","sponsor":"John Yanik","startDate":"2018-09-04","conditions":"Opioid Use","enrollment":48},{"nctId":"NCT02432456","phase":"PHASE4","title":"Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2015-09","conditions":"Wounds and Injuries, Rib Fractures","enrollment":153},{"nctId":"NCT03803371","phase":"PHASE4","title":"Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets","status":"COMPLETED","sponsor":"Pfizer","startDate":"2019-03-26","conditions":"Healthy","enrollment":60},{"nctId":"NCT03415243","phase":"PHASE1","title":"To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-03-01","conditions":"Common Cold","enrollment":28},{"nctId":"NCT03193658","phase":"NA","title":"USG Thoracolumbar Interfascial Plane (TLIP) in Lumbar Spine Surgeries","status":"COMPLETED","sponsor":"Eslam Ayman Mohamed Shawki","startDate":"2017-08-01","conditions":"Regional Anesthesia","enrollment":34},{"nctId":"NCT02029638","phase":"PHASE2","title":"BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2014-01-07","conditions":"Kidney Transplantation","enrollment":4},{"nctId":"NCT03385057","phase":"PHASE1","title":"Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy","status":"WITHDRAWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2018-09","conditions":"Tonsillectomy With or Without Adenoidectomy","enrollment":""},{"nctId":"NCT02143141","phase":"PHASE4","title":"Low Pain Prediction in Cesarean Section Patients","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-11","conditions":"Scheduled Cesarean Sections, Postoperative Pain Management, Side Effects","enrollment":13},{"nctId":"NCT00078559","phase":"PHASE1, PHASE2","title":"Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2003-11","conditions":"Kidney Transplantation, Kidney Disease","enrollment":10},{"nctId":"NCT01985126","phase":"PHASE2","title":"An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2013-09-27","conditions":"Multiple Myeloma","enrollment":124},{"nctId":"NCT02204813","phase":"PHASE1","title":"To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2014-07","conditions":"Bypass, Gastric, Roux-en-Y Gastric Bypass, Vertical Sleeve Gastrectomy","enrollment":13},{"nctId":"NCT00481832","phase":"PHASE2","title":"Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Stanford University","startDate":"2007-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":50},{"nctId":"NCT02785003","phase":"PHASE4","title":"Ketamine in Colorectal Surgery","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2016-07","conditions":"Acute Pain, Pain, Postoperative, Colorectal Surgery","enrollment":""},{"nctId":"NCT01535001","phase":"NA","title":"Structured Non-operative Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Northern Orthopaedic Division, Denmark","startDate":"2012-02","conditions":"Osteoarthritis of the Knee","enrollment":100},{"nctId":"NCT01410409","phase":"NA","title":"Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement","status":"COMPLETED","sponsor":"Northern Orthopaedic Division, Denmark","startDate":"2011-09","conditions":"Osteoarthritis of the Knee","enrollment":100},{"nctId":"NCT00679614","phase":"PHASE3","title":"Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2007-12-17","conditions":"Hip Arthroplasty, Knee Arthroplasty, Spinal Anesthesia","enrollment":45},{"nctId":"NCT02655458","phase":"PHASE1","title":"Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma","status":"COMPLETED","sponsor":"Hearn Jay Cho","startDate":"2016-01","conditions":"Multiple Myeloma","enrollment":15},{"nctId":"NCT01382940","phase":"PHASE4","title":"A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-07-26","conditions":"Rheumatoid Arthritis","enrollment":351},{"nctId":"NCT02613910","phase":"PHASE3","title":"Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2015-12-23","conditions":"Pemphigus","enrollment":1},{"nctId":"NCT02958566","phase":"PHASE4","title":"Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery","status":"UNKNOWN","sponsor":"University of Illinois College of Medicine at Peoria","startDate":"2017-01","conditions":"Colon Cancer, Colon Diverticulosis, Colonic Neoplasms","enrollment":80},{"nctId":"NCT02922075","phase":"PHASE4","title":"Impact of Soft Tissue Grafts on Tissue Alterations After Immediate Tooth Replacement","status":"COMPLETED","sponsor":"São Paulo State University","startDate":"2013-02","conditions":"Tooth Socket, Dental Implants","enrollment":24},{"nctId":"NCT02091297","phase":"NA","title":"Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone","status":"WITHDRAWN","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-04","conditions":"Caesarean Delivery","enrollment":""},{"nctId":"NCT00248625","phase":"PHASE3","title":"N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2000-01","conditions":"Acute Liver Failure, Hepatic Encephalopathy","enrollment":184},{"nctId":"NCT00849745","phase":"PHASE1","title":"Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases","status":"TERMINATED","sponsor":"Duke University","startDate":"2003-01","conditions":"Systemic Lupus Erythematosus, Systemic Sclerosis","enrollment":4},{"nctId":"NCT01823224","phase":"NA","title":"Comparing Effectiveness of IV vs Oral Acetaminophen Given Perioperatively for Lap Choles for Pain Control,","status":"COMPLETED","sponsor":"Defense and Veterans Center for Integrative Pain Management","startDate":"2013-02","conditions":"Laparoscopic Cholecystectomy","enrollment":67},{"nctId":"NCT00737048","phase":"PHASE3","title":"A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2008-03","conditions":"Pain, Postoperative Pain","enrollment":328},{"nctId":"NCT02541643","phase":"","title":"Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma","status":"NO_LONGER_AVAILABLE","sponsor":"Sundar Jagannath","startDate":"","conditions":"Multiple Myeloma","enrollment":""},{"nctId":"NCT01711229","phase":"PHASE4","title":"Equality Study of Ofirmev vs Oral Acetaminophen","status":"UNKNOWN","sponsor":"Babiash, Kimberly H., M.D.","startDate":"2015-12","conditions":"Pain, Postoperative","enrollment":114},{"nctId":"NCT00770562","phase":"PHASE3","title":"A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-07","conditions":"Idiopathic Thrombocytopenic Purpura","enrollment":103},{"nctId":"NCT00795132","phase":"PHASE2","title":"Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"University of Utah","startDate":"2004-04","conditions":"Acute Leukaemia, Chronic Disease, Leukemia","enrollment":47},{"nctId":"NCT00982800","phase":"PHASE4","title":"Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy?","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2007-06","conditions":"Prostate Cancer","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":634,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Acetaminophen (or equivalent)","genericName":"Acetaminophen (or equivalent)","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. Used for Mild to moderate pain, Fever reduction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}